![Janet Hopkins](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Janet Hopkins
Technik-/Wissenschafts-/F&E-Leiter bei
AURA BIOSCIENCES, INC.
Vermögen: 3 Mio $ am 31.08.2026
Profil
Janet Jill Hopkins is Director at Gyroscope Therapeutics Holdings Plc since 2022 and Chief Medical Officer at Aura Biosciences, Inc. since 2023.
Former roles include Chief Executive Officer at Gyroscope Therapeutics Ltd. from 2021 to 2023 and SVP, Global Head-Ophthalmology & Exploratory at Novartis AG from 2021 to 2023.
Education includes a doctorate from McMaster University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
AURA BIOSCIENCES INC 0.37% | 01.09.2026 | 380’190 ( 0.37% ) | 3 Mio $ | 31.08.2026 |
Aktive Positionen von Janet Hopkins
| Unternehmen | Position | Beginn |
|---|---|---|
| GYROSCOPE THERAPEUTICS HOLDINGS PLC | Direktor/Vorstandsmitglied | 17.02.2022 |
| AURA BIOSCIENCES, INC. | Technik-/Wissenschafts-/F&E-Leiter | 16.10.2023 |
Ehemalige bekannte Positionen von Janet Hopkins
| Unternehmen | Position | Ende |
|---|---|---|
| NOVARTIS AG | Corporate Officer/Principal | 01.10.2023 |
Gyroscope Therapeutics Ltd.
 Gyroscope Therapeutics Ltd. BiotechnologyHealth Technology Develops gene therapies and medicines for eye diseases | Vorstandsvorsitzender | 01.10.2023 |
Ausbildung von Janet Hopkins
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
55
Beziehungen ersten Grades
5
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Aura Biosciences, Inc.
 Aura Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company leveraging novel targeted oncology platform to develop new standard of care across multiple cancer indications | Health Technology |
Novartis AG
 Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
McMaster University
 McMaster University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gyroscope Therapeutics Ltd.
Gyroscope Therapeutics Ltd. BiotechnologyHealth Technology Develops gene therapies and medicines for eye diseases | Health Technology |
Gyroscope Therapeutics Holdings Plc
 Gyroscope Therapeutics Holdings Plc BiotechnologyHealth Technology Develops clinical-stage gene therapies to treat diseases of eyes | Health Technology |
